[EN] NOVEL PYRIDO[2,3-B]PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS<br/>[FR] NOUVELLES PYRIDO [2,3-B] PYRAZINONES UTILISÉES EN TANT QU'INHIBITEURS DE BROMODOMAINES DE LA FAMILLE BET
申请人:PFIZER
公开号:WO2016203335A1
公开(公告)日:2016-12-22
Disclosed are novel pyrido[2,3-b]pyrazinones of formulae (I) and (II) or pharmaceutically acceptable salts thereof. Pharmaceutical compositions and the use of the compounds to treat diseases or disorders that are BET family bromodomain-dependent, e.g. cancer, are also disclosed. Methods for preparing and using these compounds are further described.
揭示了新型的式(I)和(II)的吡啶并[2,3-b]吡唑酮,或其药学上可接受的盐。还披露了将这些化合物用于治疗依赖于BET家族溴结构域的疾病或紊乱,如癌症的药物组合物和使用方法。进一步描述了制备和使用这些化合物的方法。